_______________________________________________________________________Referências
108
THIJSSEN, V.L., HULSMANS, S., GRIFFIOEN, A.W. The galectin profile of the
endothelium: altered expression and localization in activated and tumor endothelial cells. The
American journal of pathology (Bethesda), 2008, vol. 172(2), p. 545-53.
TOSCANO, M.A., BIANCO, G.A., ILARREGUI, J.M., CROCI, D.O., CORREALE, J.,
HERNANDEZ, J.D., ZWIRNER, N.W., POIRIER, F., RILEY, E.M., BAUM, L.G.,
RABINOVICH, G.A. Differential glycosylation of TH1, TH2 and TH-17 effector cells
selectively regulates susceptibility to cell death. Nature immunology (New York), 2007, vol.
8(8), p. 825-34.
TOSCANO, M.A., COMMODARO, A.G., ILARREGUI, J.M., BIANCO, G.A., LIBERMAN,
A., SERRA, H.M., HIRABAYASHI, J., RIZZO, L.V., RABINOVICH, G.A. Galectin-1
suppresses autoimmune retinal disease by promoting concomitant Th2-and T regulatory-
mediated anti-inflammatory responses. Journal of immunology (Baltimore), 2006, vol. 176(10),
p. 6323-32.
VAN DER LEIJ, J., VAN DEN BERG, A., BLOKZIJL, T., HARMS, G., VAN GOOR, H.,
ZWIERS, P., VAN WEEGHEL, R., POPPEMA, S., VISSER, L. Dimeric galectin-1 induces
IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response.
The Journal of Parasitology (Lawrencce), 2004, vol.204(5), p.511-8.
VAN DER LEIJ, J., VAN DEN BERG, A., HARMS, G., ESCHBACH, H., VOS, H., ZWIERS,
P., VAN WEEGHEL, R., GROEN, H., POPPEMA, S., VISSER, L. Strongly enhanced IL-10
production using stable galectin-1 homodimers. Molecular immunology (Oxford), 2007, vol.
44(4), p. 506-13.
VARKI, A., CUMMINGS, R. D., ESKO, J., FREEZE, H., HART, G., AND MARTH, J.
Essentials of Glycobiology, 1st Ed., Cold Spring Harbor Laboratory Press, Inc., (Boston), 1999.
VESPA, G.N., LEWIS, L.A., KOZAK, K.R., MORAN, M., NGUYEN, J.T., BAUM, L.G.,
MICELI, M.C. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but
inhibit IL-2 production and proliferation. Journal of immunology (Baltimore), 1999, vol. 162,
p. 799–806.
VILLARINO, A., HIBBERT, L., LIEBERMAN, L., WILSON, E., MAK, T., YOSHIDA, H.,
KASTELEIN, R.A., SARIS, C., HUNTER, C.A. The IL-27R (WSX-1) is required to suppress T
cell hyperactivity during infection. Immunity (Cambridge), 2003, vol. 19(5), p. 645-55.
VILLEGAS, E.N., WILLE, U., CRAIG, L., LINSLEY, P.S., RENNICK, D.M., PEACH, R.,
HUNTER, C.A. Blockade of costimulation prevents infection-induced immunopathology in
interleukin-10-deficient mice. Infection and immunity (Washington), 2000, vol. 68(5), p. 2837-
44.
VOGEL, N., KIRISITS, M., MICHAEL, E., BACH, H., HOSTETTER, M., BOYER, K.,
SIMPSON, R., HOLFELS, E., HOPKINS, J., MACK, D., METS, M.B., SWISHER, C.N.,
PATEL, D., ROIZEN, N., STEIN, L., STEIN, M., WITHERS, S., MUI, E., EGWUAGU, C.,
REMINGTON, J., DORFMAN, R., MCLEOD, R. Congenital toxoplasmosis transmitted from
an immunologically competent mother infected before conception. Clinical infectious diseases :
an official publication of the Infectious Diseases Society of America (Chicago), 1996, vol.
23(5), p.1055-60.
VOSSENKÄMPER, A., STRUCK, D., ALVARADO-ESQUIVEL, C., WENT, T., TAKEDA,
K., AKIRA, S., PFEFFER, K., ALBER, G., LOCHNER, M., FÖRSTER, I., LIESENFELD, O.
Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral